Practo
Practo delivers 3,500 Cr GMV in FY24; narrows EBITDA losses by 82%
Exclusive: Decoding Practo’s $32 Mn fresh round with 50% lower valuation
Exclusive: Amidst churn at the top, Practo selling Enlightiks in a fire sale
Matrix India announces $300 Mn Fund III; sharp focus on consumer segment
Delhi High Court hammers nationwide ban on online sale of medicines